US’ top IV fluid maker Baxter voices uncertainty about recovery timeline at North Carolina facility hit by Helene fkansteiner Fri, 10/04/2024 – 12:54 More: US' top IV fluid maker Baxter voices uncertainty about recovery timeline at North Carolina facility hit
read moreBeiGene launches PD-1 drug Tevimbra at 10% discount to Merck’s Keytruda aliu Fri, 10/04/2024 – 10:42 More: BeiGene launches PD-1 drug Tevimbra at 10% discount to Merck's Keytruda Source: fierce
read moreAmerican Society for Meningitis Prevention paints the town purple and blue for World Meningitis Day apark Fri, 10/04/2024 – 10:14 More: American Society for Meningitis Prevention paints the town purple and blue for World Meningitis Day Source: fierce
read moreIn sustained rare disease push, Recordati lays out $825M upfront to acquire Sanofi’s CAD drug Enjaymo fkansteiner Fri, 10/04/2024 – 09:38 More: In sustained rare disease push, Recordati lays out 5M upfront to acquire Sanofi's CAD drug Enjaymo Source: fierce
read moreBMS’ Opdivo joins the perioperative lung cancer treatment ring with key FDA approval zbecker Thu, 10/03/2024 – 15:24 More: BMS' Opdivo joins the perioperative lung cancer treatment ring with key FDA approval Source: fierce
read moreNHS England proposes phased rollout for Eli Lilly’s star obesity drug kdunleavy Thu, 10/03/2024 – 14:47 More: NHS England proposes phased rollout for Eli Lilly's star obesity drug Source: fierce
read more© 1994 - 2025 B.M. Pharmaceuticals